CpG-Tag-NP immunization led to increased accumulation of CD8+ and CD4+ T cells expressing the activation marker CD69 in BALF when immunized mice were challenged with 4T1 tumor cells via tail vein injection (Figure 3C,D). The gene discussed is CD8A; the disease is neoplasm.